Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Lower SHBG levels may increase the risk of PCOS.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

All three treatments reduce hirsutism, but spironolactone works best long-term.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.